Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 version (5th JSH‐HCC Guidelines)

Hasegawa, Kiyoshi; Takemura, Nobuyuki; Yamashita, Tatsuya; Watadani, Takeyuki; Kaibori, Masaki; Kubo, Shoji; Shimada, Mitsuo; Nagano, Hiroaki; Hatano, Etsuro; Aikata, Hiroshi; Iijima, Hiroko; Ueshima, Kazuomi; Ohkawa, Kazuyoshi; Genda, Takuya; Tsuchiya, Kaoru; Torimura, Takuji; Ikeda, Masafumi; Furuse, Junji; Akahane, Masaaki; Kobayashi, Satoshi; Sakurai, Hideyuki; Takeda, Atsuya; Murakami, Takamichi; Motosugi, Utaroh; Matsuyama, Yutaka; Kudo, Masatoshi; Tateishi, Ryosuke; committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma, Tokyo, Japan, The

doi:10.1111/hepr.13892

Public

Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 version (5th JSH‐HCC Guidelines)

Shared by NobleBlocks on Mar 10, 2023 • 12:00 AM UTC

Authors:

Kiyoshi Hasegawa

Nobuyuki Takemura

Tatsuya Yamashita

Abstract

Abstract The fifth version of the Clinical Practice Guidelines for Hepatocellular Carcinoma was revised by the Japan Society of Hepatology, according to the methodology of evidence‐based medicine and partly to the Grading of Recommendations Assessment, Development and Evaluation system, which was pu...

Discussions